mrna biontech 相關
廣告Rigorous Quality Control Protocols. Concierge customer and technical support. Inquire. Our service: IVT mRNA design/modification/production/T-cell transfection&characterization.
- RNA-Protein Interactions
RIP-seq for RNA-Protein Interaction
RAP for RNA-Protein Interaction
- mRNA Stability Test
Actinomycin D-based method
Tet-off regulatory promoter system
- Delivery Vehicle for mRNA
Lipid-based vectors
Polymer-based vectors
- mRNA Reprogramming
T Cell Reprogramming by mRNA
DC Reprogramming by mRNA
- mRNA-based Assays
Nuclease Protection Assay
PrimeFlow RNA Assay
- mRNA Structure Prediction
RNA Structure Prediction
In Silico mRNA Studies
- RNA-Protein Interactions
搜尋結果
Home. Research & Innovation. Drug Classes. mRNA therapeutics and vaccines. Why mRNA represents a disruptive new drug class. Messenger RNA, or mRNA, represents one of the first molecules of life and is found in all living cells. It is composed of four different building blocks called nucleotides.
- mRNA
Durch die Trennung der zu vervielfältigenden ...
- Drug Classes
We also see opportunity for new modalities such as mRNA ...
- Small Molecule Immunomodulators
At BioNTech, we are focused on developing Small ...
- Protein-based Therapeutics
At BioNTech, we use our expertise to harness different ...
- Protein-based Platforms
At a glance: Our Next-generation Checkpoint ...
- Connect
At BioNTech, we believe that acting ethically and ...
- mRNA
2022年4月1日 · 復星醫藥向中國引進mRNA疫苗的申請尚未獲批准。 上海市政府的支持政策公布後，復星醫藥 (02196)A股飆升逾7.7%，港股收漲8.3%。 與此同時，中國藥監局2月12日附條件批准進口輝瑞公司新冠口服藥奈瑪特韋片/利托那韋片組合包裝（即Paxlovid）。 涉及新冠藥物的中外合作洽談仍在進行。...
參見. 參考資料. 外部連結. 辉瑞-BioNTech 2019冠状病毒病疫苗 [5] （英語： Pfizer–BioNTech COVID-19 vaccine ，簡稱： 輝瑞BNT疫苗 、 輝瑞疫苗 、 BNT疫苗 [4] ，代號： BNT162b2 ， 商品名 ： Comirnaty [2] 、 復必泰 ， 國際非專利藥品名稱 ：tozinameran [1] ），是一種專門對抗 严重急性呼吸系统综合征冠状病毒2 （SARS-CoV2）的 2019冠状病毒病疫苗 [3] ，為一種 信使核糖核酸 （mRNA）疫苗 [6] ，由德國 BioNTech 及美國 輝瑞 合作開發 [7] [8] 。
At a glance: Our FixVac Platform. Concept: Fixed combination of mRNA-encoded tumor antigens shared within specific cancer types aiming to trigger a strong and precise immune response against cancer cells expressing the respective antigen. mRNA Format: Optimized uridine mRNA (uRNA) for improved vaccine efficacy.
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech. For its development, BioNTech collaborated with the American company Pfizer to carry out clinical trials , logistics, and manufacturing.
2020年12月10日 · BNT162b2 is a lipid nanoparticle–formulated, nucleoside-modified RNA vaccine that encodes a prefusion stabilized, membrane-anchored SARS-CoV-2 full-length spike protein. The primary end points were...
2021年8月25日 · Pfizer and BioNTech co-developed five mRNA vaccine candidates that encode variants of the spike protein antigen 119.
